Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
The role of estrogen receptor beta in breast cancer | Biomarker Research | Full Text
New insights into acquired endocrine resistance of breast cancer
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Estrogen Receptor Pathway | Progestogen Rectieptor Signaling
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Cross-talk between nuclear receptors and nuclear factor κB | Oncogene
EREs).
Dual-mechanism estrogen receptor inhibitors | PNAS
Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer | Breast Cancer Research | Full Text
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Impact of Apparent Antagonism of Estrogen Receptor β by Fulvestrant on Anticancer Activity of 2-Methoxyestradiol | Anticancer Research
Dual-mechanism estrogen receptor inhibitors | PNAS
Estrogen receptor-α signaling in post-natal mammary development and breast cancers | SpringerLink
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Transrepression of estrogen receptor and NFκB. (a) NFκB can inhibit... | Download Scientific Diagram
Frontiers | Involvement of the Estrogen and Progesterone Axis in Cancer Stemness: Elucidating Molecular Mechanisms and Clinical Significance
Signaling pathways and steroid receptors modulating estrogen receptor α function in breast cancer
New insights into acquired endocrine resistance of breast cancer
